These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 48826)

  • 1. Letter: Adrenal suppression by clobetasol propionate.
    Ortega E; Burdick KH; Segre EJ
    Lancet; 1975 May; 1(7917):1200. PubMed ID: 48826
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Adrenal unresponsiveness associated with clobetasol propionate.
    Feiwel M; Kelly WF
    Lancet; 1974 Jul; 2(7872):112-3. PubMed ID: 4136855
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionate.
    Walker SR; Wilson L; Fry L; James VH
    Br J Dermatol; 1974 Sep; 91(3):339-43. PubMed ID: 4447661
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the systemic effect of topical clobetasol propionate (Dermovate).
    Carruthers JA; August PJ; Staughton RC
    Br Med J; 1975 Oct; 4(5990):203-4. PubMed ID: 1191997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
    Novak E; Francom SF; Schlagel CA
    Clin Ther; 1983; 6(1):59-71. PubMed ID: 6370438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on adrenal function of topically applied clobetasol propionate (Dermovate).
    Allenby CF; Main RA; Marsden RA; Sparkes CG
    Br Med J; 1975 Dec; 4(5997):619-21. PubMed ID: 1203701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
    Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
    Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
    Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
    Eriksen K
    Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment.
    Boxley JD; Dawber RP; Summerly R
    Br Med J; 1975 May; 2(5965):255-6. PubMed ID: 1131576
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of intranasal betamethasone-17-valerate on perennial rhinitis and adrenal function.
    Czarny D; Brostoff J
    Lancet; 1968 Jul; 2(7561):188-90. PubMed ID: 4173404
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clobetasol propionate (Dermovat): a new glucocorticoid preparation for local application. Comparison with betamethasone dipropionate (Diproderm)].
    Eriksen K
    Ugeskr Laeger; 1979 Aug; 141(35):2387-9. PubMed ID: 483428
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring adrenal function in out-patients using topical corticosteroids.
    Sparkes CG
    Br J Dermatol; 1976 Mar; 94 suppl 12():77-82. PubMed ID: 1268080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-acting parenteral corticosteroids on adrenal function.
    Mikhail GR; Livingood CS; Mellinger RC; Paige TN; Salyer HL
    Arch Dermatol; 1969 Sep; 100(3):263-8. PubMed ID: 4241801
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic effects of 0.064% betamethasone dipropionate ointment and cream by simple application - with emphasis upon the suppression of adrenocortical functions.
    Aso M; Shimao S
    J Dermatol; 1983 Feb; 10(1):55-62. PubMed ID: 6345622
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of betamethasone valerate inhalation on the hypothalamic-pituitary-adrenal axis or normal adults.
    Friedman M; Frears J; Crowley MF
    Postgrad Med J; 1974 Sep; 50 suppl 4():11-14. PubMed ID: 4467151
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal function during topical oral corticosteroid treatment.
    Lehner T; Lyne C
    Br Med J; 1969 Oct; 4(5676):138-41. PubMed ID: 4309863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 20. Diprosone ointment in psoriasis. A double-blind trial.
    Ross CM
    S Afr Med J; 1974 Oct; 48(48):2030-2. PubMed ID: 4612753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.